Among these ligands, TLR2/4 agonist Bacillus Calmette-Guérin (BCG), TLR4 agonist monophosphoryl lipid A (MPL), and TLR7 agonist imiquimod have been approved for use in cancer therapy [19,20,21,22,23]. Here, TLR2 is linked to cancer.